Merck & Company Inc (MRK)vsMettler-Toledo International Inc (MTD)
MRK
Merck & Company Inc
$109.18
-1.60%
HEALTHCARE · Cap: $274.03B
MTD
Mettler-Toledo International Inc
$1,240.15
-1.77%
HEALTHCARE · Cap: $25.11B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 1515% more annual revenue ($65.01B vs $4.03B). MRK leads profitability with a 28.1% profit margin vs 21.6%. MTD appears more attractively valued with a PEG of 2.63. MTD earns a higher WallStSmart Score of 66/100 (B-).
MRK
Buy59
out of 100
Grade: C
MTD
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-13.2%
Fair Value
$96.48
Current Price
$109.18
$12.70 premium
Margin of Safety
-63.3%
Fair Value
$853.06
Current Price
$1240.15
$387.09 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Every $100 of equity generates 37 in profit
Strong operational efficiency at 32.8%
Keeps 28 of every $100 in revenue as profit
Attractively priced relative to earnings
Generating 1.8B in free cash flow
Strong operational efficiency at 30.7%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Every $100 of equity generates 30 in profit
Keeps 22 of every $100 in revenue as profit
Areas to Watch
Weak financial health signals
Expensive relative to growth rate
Earnings declined 19.3%
Moderate valuation
Weak financial health signals
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Return on Equity, Operating Margin. Profitability is solid with margins at 28.1% and operating margin at 32.8%.
Bull Case : MTD
The strongest argument for MTD centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 21.6% and operating margin at 30.7%.
Bear Case : MRK
The primary concerns for MRK are Piotroski F-Score, PEG Ratio, EPS Growth.
Bear Case : MTD
The primary concerns for MTD are P/E Ratio, Piotroski F-Score, PEG Ratio.
Key Dynamics to Monitor
MRK profiles as a value stock while MTD is a mature play — different risk/reward profiles.
MTD carries more volatility with a beta of 1.44 — expect wider price swings.
MTD is growing revenue faster at 8.1% — sustainability is the question.
MRK generates stronger free cash flow (1.8B), providing more financial flexibility.
Bottom Line
MTD scores higher overall (66/100 vs 59/100), backed by strong 21.6% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Mettler-Toledo International Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Mettler Toledo (NYSE: MTD) is a multinational manufacturer of scales and analytical instruments. It is the largest provider of weighing instruments for use in laboratory, industrial, and food retailing applications. The company also provides various analytical instruments, process analytics instruments, and end-of-line inspection systems.
Visit Website →Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?